From: Pipeline progress and portfolio management of the top 30 pharma companies over the past two decades
Company | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Mean (by company) | SD (by company) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AbbVie | 2.0 | 3.6 | 2.7 | 5.1 | 0.6 | 0.6 | 6.0 | 2.5 | 3.7 | 2.4 | 4.1 | 3.0 | 3.6 | 3.2 | 2.2 | 3.0 | 1.4 | ||||||
Abbott | 6.0 | 4.3 | 3.3 | 4.4 | 2.1 | 1.8 | 2.6 | 1.9 | 1.6 | 1.9 | 2.0 | 1.9 | 3.0 | 3.5 | 2.5 | 2.9 | 1.2 | ||||||
Allergan | 1.2 | 1.0 | 4.0 | 2.9 | 2.0 | 1.9 | 1.1 | 1.6 | 1.2 | 1.9 | 0.8 | 1.6 | 1.8 | 2.7 | 0.8 | 2.6 | 2.1 | 2.6 | 1.4 | 1.8 | 0.8 | ||
Amgen | 2.4 | 1.7 | 3.3 | 3.1 | 3.0 | 3.4 | 3.3 | 2.8 | 2.9 | 1.7 | 2.2 | 2.4 | 1.9 | 2.7 | 1.9 | 3.9 | 3.2 | 3.1 | 2.9 | 2.7 | 0.6 | ||
Astellas Pharma | 0.6 | 2.3 | 3.2 | 1.9 | 2.8 | 1.9 | 1.7 | 1.3 | 1.5 | 1.1 | 2.0 | 2.0 | 3.0 | 2.4 | 0.3 | 1.0 | 0.6 | 0.2 | 0.9 | 0.7 | 1.6 | 0.9 | |
AstraZeneca | 5.5 | 3.0 | 1.5 | 2.8 | 2.5 | 2.2 | 2.5 | 1.8 | 1.2 | 0.8 | 1.1 | 0.9 | 1.2 | 2.1 | 2.2 | 2.6 | 1.4 | 2.5 | 2.7 | 2.8 | 3.0 | 2.2 | 1.0 |
Bausch & Lomb | 1.5 | 0.8 | 2.7 | 1.8 | 1.8 | 0.7 | 0.9 | 0.9 | 0.9 | 1.5 | 2.5 | 2.2 | 1.4 | 1.0 | 1.3 | 0.9 | 0.6 | 1.2 | 1.7 | 1.5 | 1.4 | 0.6 | |
Bayer | 6.8 | 2.7 | 2.7 | 1.5 | 1.3 | 2.1 | 1.7 | 2.6 | 3.1 | 2.9 | 1.6 | 2.2 | 3.4 | 2.6 | 2.1 | 2.1 | 3.6 | 1.9 | 1.5 | 2.1 | 2.2 | 2.5 | 1.1 |
Biogen | 5.0 | 3.5 | 1.7 | 1.4 | 5.4 | 1.7 | 2.0 | 2.0 | 0.9 | 1.2 | 1.5 | 1.7 | 2.1 | 1.9 | 1.1 | 2.1 | 3.1 | 1.8 | 1.6 | 2.2 | 1.2 | ||
Boehringer Ingelheim | 2.6 | 2.2 | 1.5 | 1.3 | 1.0 | 3.3 | 1.0 | 4.0 | 6.1 | 4.4 | 3.5 | 2.9 | 1.1 | 1.6 | 1.0 | 1.0 | 1.5 | 1.0 | 1.8 | 1.1 | 1.4 | 2.2 | 1.4 |
Bristol-Myers Squibb | 6.9 | 3.0 | 3.1 | 2.5 | 1.5 | 3.3 | 2.1 | 3.4 | 2.2 | 2.5 | 1.7 | 2.9 | 1.8 | 2.6 | 1.3 | 3.0 | 2.5 | 2.3 | 1.0 | 2.6 | 0.9 | 2.5 | 1.2 |
CSL Behring | 2.9 | 0.6 | 0.3 | 1.4 | 0.8 | 1.7 | 2.1 | 1.2 | 0.1 | 3.8 | 3.7 | 2.8 | 0.6 | 1.7 | 1.2 | ||||||||
Daiichi Sankyo | 4.5 | 3.8 | 2.5 | 2.6 | 1.8 | 1.6 | 1.4 | 1.0 | 1.6 | 2.8 | 1.7 | 3.5 | 1.7 | 1.5 | 0.6 | 0.8 | 1.6 | 1.7 | 3.4 | 0.7 | 2.4 | 2.1 | 1.0 |
Eisai | 6.9 | 3.5 | 2.9 | 3.1 | 3.4 | 2.1 | 1.9 | 2.4 | 1.4 | 3.0 | 2.6 | 1.4 | 1.0 | 1.3 | 1.7 | 2.2 | 1.4 | 3.8 | 2.2 | 2.5 | 1.3 | ||
Eli Lilly and Company | 8.1 | 2.5 | 2.8 | 2.2 | 2.2 | 3.4 | 2.7 | 2.5 | 3.0 | 2.4 | 2.1 | 1.6 | 1.7 | 1.1 | 2.1 | 1.6 | 1.3 | 1.0 | 1.4 | 1.4 | 1.3 | 2.3 | 1.4 |
Gilead Sciences | 13.3 | 1.9 | 3.3 | 2.8 | 5.7 | 4.6 | 4.9 | 2.7 | 3.3 | 2.4 | 2.2 | 2.4 | 1.8 | 1.9 | 2.3 | 3.1 | 2.1 | 1.8 | 1.8 | 1.5 | 3.3 | 2.5 | |
GlaxoSmithKline | 5.2 | 3.1 | 2.1 | 2.3 | 2.4 | 1.4 | 1.5 | 1.2 | 1.3 | 1.4 | 1.2 | 1.5 | 1.2 | 1.1 | 1.5 | 1.1 | 1.5 | 1.9 | 1.7 | 2.8 | 3.1 | 1.9 | 1.0 |
Johnson & Johnson | 1.7 | 2.8 | 1.6 | 0.8 | 1.6 | 1.3 | 2.7 | 1.7 | 1.5 | 1.7 | 1.2 | 0.9 | 1.2 | 1.1 | 1.6 | 1.8 | 1.3 | 1.8 | 1.6 | 2.1 | 1.9 | 1.6 | 0.5 |
Merck Sharp & Dohme | 2.2 | 2.4 | 1.1 | 1.2 | 1.3 | 1.7 | 1.6 | 1.5 | 1.1 | 1.6 | 1.5 | 1.6 | 1.8 | 1.3 | 2.4 | 1.8 | 3.6 | 3.8 | 4.0 | 3.7 | 4.2 | 2.2 | 1.0 |
Merck KGaA | 0.8 | 2.7 | 3.2 | 3.2 | 2.3 | 3.8 | 4.3 | 2.5 | 3.8 | 3.6 | 1.3 | 3.3 | 2.4 | 2.1 | 0.9 | 1.6 | 1.3 | 2.5 | 1.1 | ||||
Mylan | 2.6 | 0.7 | 0.6 | 0.5 | 0.6 | 1.3 | 0.8 | 1.1 | 0.9 | 1.0 | 0.6 | 1.2 | 0.8 | 0.7 | 0.9 | 0.5 | 0.8 | 0.8 | 0.8 | 0.9 | 0.5 | ||
Novartis | 6.9 | 3.3 | 3.0 | 3.3 | 1.7 | 2.2 | 2.5 | 2.1 | 2.5 | 2.6 | 2.8 | 2.9 | 2.6 | 3.4 | 2.5 | 2.8 | 2.5 | 2.2 | 3.5 | 2.9 | 3.3 | 2.9 | 1.0 |
Novo Nordisk | 0.8 | 1.3 | 0.9 | 0.8 | 1.4 | 0.8 | 0.8 | 1.0 | 0.9 | 0.9 | 0.8 | 0.7 | 1.4 | 1.1 | 1.4 | 1.4 | 1.3 | 1.5 | 1.4 | 2.0 | 1.3 | 1.1 | 0.3 |
Otsuka | 3.3 | 2.0 | 3.9 | 2.3 | 2.2 | 2.4 | 1.7 | 2.7 | 2.3 | 2.7 | 2.0 | 1.5 | 1.7 | 1.8 | 2.7 | 0.7 | 2.9 | 2.3 | 1.0 | 1.2 | 2.2 | 0.8 | |
Pfizer | 3.0 | 3.7 | 3.5 | 2.2 | 1.9 | 2.2 | 1.6 | 1.4 | 1.5 | 1.2 | 1.0 | 1.1 | 1.6 | 1.3 | 1.3 | 1.7 | 1.5 | 1.6 | 1.3 | 1.0 | 1.1 | 1.7 | 0.8 |
Roche | 4.8 | 4.8 | 5.3 | 4.4 | 3.0 | 3.6 | 3.6 | 2.6 | 2.7 | 2.6 | 2.6 | 2.4 | 2.2 | 2.4 | 3.1 | 3.3 | 2.6 | 3.3 | 2.7 | 3.1 | 3.5 | 3.3 | 0.9 |
Sanofi | 3.5 | 3.1 | 2.4 | 2.0 | 2.2 | 2.0 | 2.8 | 1.8 | 1.7 | 1.5 | 1.9 | 2.1 | 1.7 | 1.6 | 1.5 | 1.6 | 1.6 | 1.7 | 1.4 | 1.7 | 3.5 | 2.1 | 0.6 |
Takeda | 3.3 | 5.8 | 2.6 | 2.0 | 1.0 | 1.1 | 1.5 | 1.3 | 1.5 | 1.6 | 2.1 | 1.5 | 1.7 | 1.2 | 1.4 | 1.7 | 1.6 | 1.4 | 0.7 | 1.0 | 1.5 | 1.8 | 1.0 |
Teva | 1.0 | 0.3 | 0.3 | 0.1 | 0.4 | 1.0 | 0.2 | 0.6 | 1.9 | 2.4 | 3.7 | 1.5 | 1.1 | 0.8 | 0.8 | 1.4 | 0.5 | 2.6 | 2.8 | 2.1 | 1.3 | 1.0 | |
UCB | 3.5 | 5.4 | 1.8 | 2.4 | 2.4 | 2.3 | 1.9 | 2.0 | 2.3 | 3.3 | 2.8 | 2.9 | 1.5 | 1.4 | 1.9 | 8.5 | 1.2 | 2.9 | 1.8 | 2.6 | 3.0 | 2.8 | 1.6 |
Mean (by year) | 4.3 | 3.1 | 2.5 | 2.2 | 2.1 | 2.3 | 2.1 | 2.0 | 2.0 | 2.2 | 1.9 | 1.9 | 2.0 | 1.8 | 1.9 | 2.1 | 1.8 | 2.0 | 2.0 | 2.1 | 2.0 | ||
SD (by year) | 2.88 | 1.28 | 1.49 | 1.09 | 0.93 | 1.05 | 1.13 | 1.06 | 1.02 | 1.05 | 0.92 | 0.77 | 0.98 | 0.80 | 0.83 | 1.46 | 0.89 | 0.90 | 1.00 | 0.89 | 0.94 |